Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model

Stransky, Nicolai and Ganser, Katrin and Quintanilla-Martinez, Leticia and Gonzalez-Menendez, Irene and Naumann, Ulrike and Eckert, Franziska and Koch, Pierre and Huber, Stephan M. and Ruth, Peter (2023) Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model. SCIENTIFIC REPORTS, 13 (1): 20604. ISSN 2045-2322,

Full text not available from this repository. (Request a copy)

Abstract

The intermediate-conductance calcium-activated potassium channel K(Ca)3.1 has been proposed to be a new potential target for glioblastoma treatment. This study analyzed the effect of combined irradiation and K(Ca)3.1-targeting with TRAM-34 in the syngeneic, immune-competent orthotopic SMA-560/VM/Dk glioma mouse model. Whereas neither irradiation nor TRAM-34 treatment alone meaningfully prolonged the survival of the animals, the combination significantly prolonged the survival of the mice. We found an irradiation-induced hyperinvasion of glioma cells into the brain, which was inhibited by concomitant TRAM-34 treatment. Interestingly, TRAM-34 did neither radiosensitize nor impair SMA-560's intrinsic migratory capacities in vitro. Exploratory findings hint at increased TGF-beta 1 signaling after irradiation. On top, we found a marginal upregulation of MMP9 mRNA, which was inhibited by TRAM-34. Last, infiltration of CD3(+), CD8(+) or FoxP3(+) T cells was not impacted by either irradiation or K(Ca)3.1 targeting and we found no evidence of adverse events of the combined treatment. We conclude that concomitant irradiation and TRAM-34 treatment is efficacious in this preclinical glioma model.

Item Type: Article
Uncontrolled Keywords: CA2+-ACTIVATED K+ CHANNEL; INTERMEDIATE-CONDUCTANCE; MURINE ASTROCYTOMA; IMMUNE CELLS; DOUBLE-BLIND; TGF-BETA; GLIOBLASTOMA; RADIOTHERAPY; TEMOZOLOMIDE; MIGRATION;
Subjects: 500 Science > 540 Chemistry & allied sciences
Divisions: Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry II (Prof. Buschauer)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 22 Apr 2024 13:31
Last Modified: 22 Apr 2024 13:31
URI: https://pred.uni-regensburg.de/id/eprint/62955

Actions (login required)

View Item View Item